Comprehensive Respiratory Pathogens Testing
NxGen MDx has been in the fight against COVID-19 since early 2020, quickly developing and launching a COVID test that March. Since then, NxGen MDx has expanded respiratory testing options to account for the many flu season pathogens that have symptomatic overlap with COVID. When you need fast and comprehensive answers for a respiratory infection, look to NxGen MDx.
Understanding Respiratory Symptoms
Many respiratory infections, such as COVID-19 and the flu, share similar symptoms which can be hard to distinguish on your own. Testing from NxGen MDx can identify the specific pathogen causing your illness and provide you guidance on whether you are ok to return to work/school, if there are any antibiotics or medications that will help, or if you just need bed rest.
Risks of Respiratory Infections
Respiratory pathogens are some of the most common causes of infection with illness ranging from mild (such as the common cold) to potentially deadly (such as RSV or COVID-19). Comprehensive testing can help you understand your level of risk and infectiousness.
Average of 31.6 million flu cases per year since 20151
160,000+ RSV infections detected since spikes started in mid 20212
Yearly strep infections estimated at 14,000 – 25,0003
Access for All
We want our panels and tests to be affordable for everyone. If you are uninsured or think you will have difficulty paying for your screening or testing, our Access for All Program may be able to help.
Interested in NxGen MDx Respiratory Pathogen Testing?
2 – RSV Numerator Data for the US [Internet]. [cited 2022 Sep 8]. Available from: https://www.cdc.gov/surveillance/nrevss/images/trend_images/RSV14Num_Nat.htm
3 – Surveillance for Group A Strep Disease | CDC [Internet]. 2022 [cited 2022 Sep 8]. Available from: https://www.cdc.gov/groupastrep/surveillance.html
“Having a medical professional administer a specific test that detects both flu and COVID-19 allows
you to get diagnosed and treated for the specific virus you have more quickly.”
– US Centers for Disease Control and Prevention, 2023
Empowering Antibiotic Stewardship
Comprehensive testing of viral pathogens reassures patients and families when antibiotics are not needed. When bacterial pathogens are detected, antibiotic resistance and treatment guidelines are included on the report. Infectious disease experts are available for advice on both viral and bacterial infections.
23.9% of bacteria-positive cases showed evidence of antibiotic resistance.1
*Respiratory Pathogen Panel (RPP) is a seasonal product, service will resume in the fall
NxGen MDx Respiratory Pathogen Testing Benefits You and Your Patients
Partnering with NxGen MDx has positively impacted my clinical practice and patient outcomes.
Excellent customer service and any question or concern is always addressed in less than twenty-four hours. Thank you NxGen MDx!
Connect With Us
If you are interested in offering NxGen MDx Respiratory Pathogen Testing or simply want to learn more, click the button below to contact a NxGen representative.
1 – NxGen MDx. Internal Data. Collected 2020. n > 900
2 – Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing (2021, July 21). Centers for Disease Control and Prevention. https://www.cdc.gov/csels/dls/locs/2021/07-21-2021-lab-alert-Changes_CDC_RT-PCR_SARS-CoV-2_Testing_1.html
3 – Olsen, S. J. Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021. MMWR Morb. Mortal. Wkly. Rep. 70, (2021).
4 – Treatment guidelines informed by Centers for Disease Control and Prevention recommendations. Retrived from https://CDC.gov/
5 – Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD). 2022. Similarities and Differences between Flu and COVID-19. Retrieved from https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm